The Global HPV Testing & Pap Test Market is projected to reach the US $ 4.52 billion, at a CAGR of 6.6%
The Research report provides a detailed overview of Several factors such as increasing number of cervical cancer cases, growing aging population, increasing awareness of cervical cancer screening programs, and government initiative and funding are propelling the growth of the HPV testing and Pap test market.
However, changes in regulatory guidelines for cervical cancer screening and HPV vaccination are some major factors restraining the growth of this market. HPV contributes to around 90% of all anal and cervical cancers and 70% of vaginal and vulvar cancers. Pap tests are the most preferred tests to detect cervical cancer.
the uncertain reimbursement scenario serves to be a major challenge impacting the growth of the HPV test and Pap test market.
The increasing number of cervical cancer cases and the ing aging population
Cervical cancer is considered to be the fourth most prevalent forms of cancer globally and is the most common cause of death among women (Source: Global Cancer Facts and figures). It has been estimated that 527,624 new cases of cervical cancer have emerged worldwide, while 265,653 women died due to cervical cancer in 2012.
HPV Testing & Pap Test Market segmentation:
· based on products
· based on diseases
· based on techniques,
· based on end users
· based on regions.
The Major Players Operating in the HPV Testing & Pap Test Market:
Abbott Laboratories (U.S.), Qiagen N.V. (The Netherlands), Hologic Inc. (U.S.), Roche Diagnostics (Switzerland), Quest Diagnostics (U.S.), Becton, Dickinson, and Company (U.S.) are the key players operating in the HPV testing and Pap test market.
Major Developments in HPV Testing & Pap Test Market
Geographical Detailed Analysis for HPV Testing & Pap Test Market:
Geographically, the HPV testing and Pap test market are segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).
North America is expected to grow at the highest CAGR in the forecast period. Increased government funding & grants and an introduction of HPV primary tests are major factors fueling the growth of the HPV testing and Pap test market in North America.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly